Business Wire - Techseriesinsight

February 20, 2026
Business Wire
Biotechnology, News

Seaport Therapeutics Shares GAD Placebo Response Meta-Analysis at ISCTM 2026

Seaport Therapeutics Presents New GAD Findings Seaport Therapeutics presented new data on placebo response in generalized anxiety disorder (GAD) trials. The findings were shared at the International Society for...

February 20, 2026
Business Wire
Artificial Intelligence, News

G42 and Credo AI Partner to Accelerate Responsible AI in Global South

G42 and Credo AI Advance Responsible AI in Emerging Markets The G42 Credo AI partnership marks a significant step toward scaling Responsible AI adoption across the Global South. G42...

February 20, 2026
Business Wire
Biotechnology, News

Sai Life Sciences to Hire 700+ Professionals in FY27 Expansion

Sai Life Sciences hiring FY27 plans signal strong growth in India’s CRDMO sector. Sai Life Sciences announced it will recruit more than 700 scientific, technical, and management professionals during...

February 20, 2026
Business Wire
Biotechnology, News

FDA Accepts Giredestrant NDA for ESR1-Mutated Breast Cancer

Giredestrant NDA has been accepted by the U.S. Food and Drug Administration for review in patients with ESR1-mutated, ER-positive advanced breast cancer. Genentech, a member of the Roche Group,...

IDBS Wins Best Biologics Digitalisation: Software Innovation Award

February 19, 2026
Business Wire
Artificial Intelligence, News

Infobip Named RCS for Business Leader by Juniper Research

Infobip RCS leader recognition has positioned Infobip as the number one Established Leader in the Juniper Research RCS for Business 2026 Leaderboard. Juniper Research ranked Infobip first among 17...

February 19, 2026
Business Wire
Artificial Intelligence, News

Merck Reports Positive ENFLONSIA Data for High-Risk Children in Second RSV Season

ENFLONSIA RSV data from the Phase 3 SMART trial show positive results for infants and children under 2 years at increased risk for severe respiratory syncytial virus (RSV) disease....

February 19, 2026
Business Wire
Artificial Intelligence, News

London Market Brokers Prefer Digitally Advanced Insurers, Guidewire Finds

London Market brokers increasingly favor insurers that invest in modern digital technology, according to new research from Guidewire. The findings show that technology now plays a decisive role in...

February 19, 2026
Business Wire
Biotechnology, News

Brenus Pharma Highlights STC-1010 Data at AACR Immuno-Oncology 2026

Brenus Pharma presented new preclinical and early clinical data on STC-1010 in colorectal cancer at the American Association for Cancer Research Immuno-Oncology (AACR IO) Conference 2026 in Los Angeles...

February 19, 2026
Business Wire
Biotechnology, News

ENHERTU Type II Variation Validated by EMA for HER2 Positive Early Breast Cancer

The ENHERTU Type II Variation application has received validation from the European Medicines Agency (EMA) for use as a post-neoadjuvant treatment in adults with HER2 positive early breast cancer....

February 18, 2026
Business Wire
Blockchain Technology, News

Canary Staked SUI ETF Launches with Spot Exposure and Staking Rewards

Canary Capital has launched the Canary Staked SUI ETF (NASDAQ: SUIS), introducing the first spot SUI ETF with integrated staking rewards. The new fund provides investors with direct exposure...